Insight Molecular Diagnostics Inc. (IMDX)
$3.37+2.74%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $109M
- Beta
- 1.80
- P/E (TTM)
- -2.22
- Short % float
- 9.65%
- Days to cover
- 2.9
- SI change
- -2.0%
- 1W
- -2.03%
- 1M
- -15.33%
- vs SPY 1W
- -3.20%
- vs SPY 1M
- -18.32%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMDX?
- LOPJLB’s latest quantitative signal on Insight Molecular Diagnostics Inc. (IMDX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IMDX in?
- Insight Molecular Diagnostics Inc. (IMDX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Insight Molecular Diagnostics Inc. (IMDX) do?
- OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocar…